Industry Symposia at ECP 2024

Sunday, 8 September 2024

Lunch, 13:00-14:30

  • Daiichi | All you need to HER2 know
  • Johnson & Johnson / Diatech | Synergies in sight: navigating challenges of precision medicine via multidisciplinary collaboration in GU oncology
  • AstraZeneca | Beyond the human eye: diagnostic advances in digital and computational pathology
  • MSD | Navigating precision pathology: biomarkers defining treatment, tissue and liquid biopsy synergy, and collaborative patient care
  • Thermo Fisher Scientific | Precision oncology in every lab: connect next generation pathologists and researchers with NGS biomarker testing
  • Vitro.Bio | Addressing routine challenges in modern pathology

Monday, 9 September 2024

Breakfast, 07:15-08:15

  • Roche | Improving the diagnosis of B Cell lymphomas in routine pathology practice: advances in clonality evaluation
  • Eli Lilly | Power hour: the importance of pathologists for the success of clinical studies

Lunch, 13:00-14:30

  • Roche / Johnson & Johnson | Pathways to precision: practical strategies for optimizing diagnostic excellence
  • AstraZeneca | Exploring the expanding applications of ctDNA and pathway mutations in breast cancer diagnostics
  • 3D Histech | Digital Pathology, IHC and Cytology
  • gsk | Guiding clinical outcomes in gynecological cancers with early and accurate biomarker testing, including case-based examples
  • Agilent Technologies | Changing testing in gastric cancer: a practical review

Evening, 19:30-20:30

  • Epredia | Digital transformation: journey to a digital workflow

Tuesday, 10 September 2024

Lunch, 13:00-14:30

  • Roche | Precision diagnostics in ovarian cancer: traversing from testing to treatment
  • AstraZeneca | NSCLC: the evolution and expansion of testing across the care continuum
  • Astellas | The Pathologist's loom: weaving CLDN18.2 into practice
  • Illumina | Illumina's journey in precision pathology: from targeted panels to whole genome sequencing
  • Amgen | The future of pathology: liquid biopsy, novel biomarkers, and tumour-agnostic therapies
  • Agilent Technologies | How can scalable, open digital pathology solutions advance diagnostic quality and efficiency in pathology practice?

HotSpots at ECP 2024

  • Siemens Healthineers AG | 9 September 2024, 09:30-09:50, HotSpot stage at exhibition area
  • SOPHiA GENETICS | 9 September 2024, 10:00-10:20, HotSpot stage at exhibition area
  • SOPHiA GENETICS | 10 September 2024, 09:30-09:50, HotSpot stage at exhibition area
  • Sysmex Europe SE | 10 September 2024, 10:00-10:20, HotSpot stage at exhibition area